Search for: "Biotechnology Industry Organization" Results 41 - 60 of 807
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
2 Feb 2023, 9:37 pm by Jim Sedor
It is tasked with reviewing the biotech industry and suggesting investments that would benefit national security. [read post]
1 Feb 2023, 8:11 am by centerforartlaw
Under the frameworks created by the World Intellectual Property Organization (“WIPO”), this article aims to review the Intellectual Property (“IP”)-specific legal measurements in TK/TCE comprehensively. [read post]
11 Jan 2023, 11:43 am by editor@howarddc.com
Bergeson, Managing Partner, B&C, has earned an international reputation for her deep and expansive understanding of how regulatory programs pertain to nanotechnology, industrial biotechnology, synthetic biology, and other emerging transformative technologies. [read post]
  OSC will coordinate with existing organizations such as the Defense Advanced Research Projects Agency (DARPA) and the Defense Innovation Unit (DIU), which promotes acceleration of the military use of commercial technologies. [read post]
29 Nov 2022, 3:10 am by Rob Robinson
His work experience includes global responsibility for privacy in 160 countries and for over 110,000 employees for Biotechnology, Pharmaceuticals, Medical Devices and Direct to Consumer Products. [read post]
23 Nov 2022, 5:16 am by Vishnu Kannan, Mubashar Rizvi
On Oct.7, the Department of Commerce’s Bureau of Industry and Security (BIS) announced a new slate of export controls designed to restrict the People’s Republic of China’s (PRC’s) access to advanced semiconductors, supercomputers, and semiconductor manufacturing equipment. [read post]
21 Nov 2022, 5:46 am by Ryan Morhard
Industries that never before used biotechnology are starting to use biotechnology now, including sectors ranging from cosmetics and personal care to industrial chemicals. [read post]
Drawing on lessons learned from its 5G experience, China has named biotechnology a strategic emerging industry, and the government’s 14th Five-Year Plan places additional emphasis on the bioeconomy. [read post]
19 Nov 2022, 8:52 am
In that sense they provide a framework for structuring compliance and governance frameworks that can be administered by state organs and effectively delegated to enterprises (which continue to be utilized as privatized administrative agencies). [read post]
15 Nov 2022, 8:22 am by Courtenay C. Brinckerhoff
According to the Federal Register Notice, the USPTO is interested in “feedback from a broad group of stakeholders, including, but not limited to, patients and their caregivers, patient advocates, representatives from regulated industry, including companies  that sell branded medicines, generics drugs and biosimilars, healthcare organizations, payors and insurers, academic institutions, public interest groups, and the general public. [read post]
2 Nov 2022, 6:52 pm by Scott Westfahl and Anusia Gillespie
What did these three leading General Counsels from three disparate industries have to say about thriving as the clock speed of change accelerates around them and their companies? [read post]
14 Oct 2022, 5:16 am by Chenny Zhang
For large drugmakers, this is usually done in house or outsourced to contract research organizations (CROs). [read post]
12 Oct 2022, 9:05 pm by Trevor Kirby
Experts also dispute the pharmaceutical industry’s assertion that permitting the Secretary of HHS to negotiate drug prices would necessarily reduce drug manufacturers’ research and development budgets. [read post]
10 Oct 2022, 5:00 am by Matthew Chun
Moreover, why should the U.S. government prop up these industries with federal funding rather than simply letting private investment do its thing? [read post]
29 Sep 2022, 12:06 pm by Verónica Rodríguez Arguijo
Effects: revolutionizing innovations in health, food, environment, and mobility (four fields of key importance to society).WIPO shared some findings in the press release published today:“[R]esearch and development (R&D) and other investments that drive worldwide innovative activity continued to boom in 2021 despite the COVID-19 pandemic.The top global corporate R&D spenders increased their R&D expenditure by almost 10 percent to over USD 900 billion in 2021, higher than in 2019… [read post]
Part One – Helpful Tips for Prosecuting Patents in the Biotechnology Space Major innovations created in the biotechnology space may encounter issues in identifying patent eligible subject matter during patent prosecution (for example, panelists explained that abstract idea and natural phenomenon-based rejections are relatively common in the art unit for Biotechnology and Organic fields). [read post]
Part One – Helpful Tips for Prosecuting Patents in the Biotechnology Space Major innovations created in the biotechnology space may encounter issues in identifying patent eligible subject matter during patent prosecution (for example, panelists explained that abstract idea and natural phenomenon-based rejections are relatively common in the art unit for Biotechnology and Organic fields). [read post]
21 Sep 2022, 6:53 am by Simmons Hanly Conroy
The National Center for Biotechnology Information currently reports that more than 250,000 people die each year from asbestos-related illnesses on average. [read post]
20 Sep 2022, 9:19 am by Rob Robinson
Industry investment trends that may have consequences for a given transaction’s impact on U.S. national security. [read post]
19 Sep 2022, 5:03 pm by Sabrina I. Pacifici
Advancing the bioeconomy is also viewed as an opportunity to create new jobs and industries, improve human health through the development of new drugs and diagnostics, and boost rural development. [read post]